A preliminary study of the role of extracellular -5'- nucleotidase in breast cancer stem cells and epithelial-mesenchymal transition.
Tumor stem cell theory may well explain a variety of malignant behaviors of tumors. Cells undergoing epithelial-mesenchymal transition (EMT) share many characteristics with tumor stem cells. Our previous studies showed that extracellular -5'- nucleotidase (CD73), one of the important surface markers of mesenchymal stem cells, may promote growth and metastasis of breast cancer cells both in vivo and in vitro. In this study, we assessed breast cancer stem cell (BCSC) markers [acetaldehyde dehydrogenase (ALDH)+and CD44+CD24-] in various breast cancer cell lines with flow cytometry after overexpression (by lentivirus infection) or suppression (by siRNA interference) of CD73. We measured CD73 expression in breast cancer mammospheres with real-time PCR and western blots. Finally, we examined the expression of CD73 and EMT markers in different breast cancer cell lines, as well as in mammary cells (MCF10A) that underwent EMT induced by transforming growth factor beta (TGF-β). We found that CD73 positively correlated with ALDH+or CD44+CD24-subsets of breast cancer cells. CD73 was expressed more in breast cancer mammospheres than in adherent cells. CD73 and mesenchymal marker expression was higher in breast cancer cells with more malignant features, while CD73 was lower in low malignant breast cancer cells with higher epithelial markers. Furthermore, CD73 expression increased during the process of TGF-β-induced EMT. Our results indicate that CD73 may play an important role in BCSCs.
Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University, No. 138 Yixueyuan Road, Shanghai, 200032, People's Republic of China.
Jiangang
J
Yu
Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University, No. 138 Yixueyuan Road, Shanghai, 200032, People's Republic of China.
Xiaohong
X
Liao
Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University, No. 138 Yixueyuan Road, Shanghai, 200032, People's Republic of China.
Luying
L
Li
Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University, No. 138 Yixueyuan Road, Shanghai, 200032, People's Republic of China.
Lei
L
Lv
Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University, No. 138 Yixueyuan Road, Shanghai, 200032, People's Republic of China.
Xiuling
X
Zhi
Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University, No. 138 Yixueyuan Road, Shanghai, 200032, People's Republic of China.|Department of Medicine, University of Louisville, Louisville, KY, 40292, USA.
Jerry
J
Yu
Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University, No. 138 Yixueyuan Road, Shanghai, 200032, People's Republic of China. zping@shmu.edu.cn.
Ping
P
Zhou
D015720:5'-Nucleotidase / Q000378:metabolism*; D001943:Breast Neoplasms / Q000473:pathology*; D045744:Cell Line, Tumor; D058750:Epithelial-Mesenchymal Transition; D005110:Extracellular Space / Q000201:enzymology*; D005260:Female; D006801:Humans; D014411:Neoplastic Stem Cells / Q000201:enzymology* / Q000473:pathology*; D011994:Recombinant Proteins / Q000378:metabolism; D018874:Spheroids, Cellular / Q000378:metabolism / Q000473:pathology
D011994:Recombinant Proteins; D015720:5'-Nucleotidase
Breast cancer; CD73; Epithelial-mesenchymal transition; Tumor stem cell
Semin Cancer Biol. 2015 Jun;32:3-9
24530939
FASEB J. 2013 Jan;27(1):13-24
23024375
IUBMB Life. 2012 Nov;64(11):911-20
23086814
Adv Pharmacol. 2011;61:301-32
21586363
Lancet Oncol. 2014 Jun;15(7):e279-89
24872111
Nat Cell Biol. 2014 Jun;16(6):488-94
24875735
Clin Exp Metastasis. 2007;24(6):439-48
17587186
Cancer Lett. 2014 Mar 28;344(2):180-7
24333726
J Cancer Res Clin Oncol. 2008 Mar;134(3):365-72
17671792
Oncol Rep. 2007 Jun;17 (6):1341-6
17487388
Oncogene. 2014 Sep 4;33(36):4451-63
24096485
Dev Cell. 2008 Jun;14(6):818-29
18539112
Clin Transl Med. 2014 Jul 02;3:17
25050175
J Biotechnol. 2010 Jul 1;148(1):3-15
20097238
Cell Stem Cell. 2014 Mar 6;14(3):275-91
24607403
Clin Cancer Res. 2013 Oct 15;19(20):5626-35
23983257
Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):11091-6
23776241
Mediators Inflamm. 2014;2014:509027
24707115
J Immunol. 2013 Oct 15;191(8):4165-73
24043904
Curr Opin Cell Biol. 2014 Dec;31:56-66
25240174
Stem Cells Dev. 2013 Aug 15;22(16):2221-39
23540661
Nat Rev Mol Cell Biol. 2014 Mar;15(3):178-96
24556840
Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):14711-6
23964122
Semin Cancer Biol. 2015 Apr;31:16-27
24956577
Cell. 2008 May 16;133(4):704-15
18485877
J Natl Cancer Inst. 2006 Dec 20;98 (24):1777-85
17179479
Cancer Treat Rev. 2014 Apr;40(3):341-8
24090504
Clin Transl Med. 2014 Oct 15;3:35
25343018
Cell Cycle. 2011 May 1;10(9):1378-84
21552008
Int J Cancer. 2014 Mar 15;134(6):1466-73
23982901
Cancer Res. 2014 Mar 1;74(5):1566-75
24413534
EMBO Rep. 2014 Mar;15(3):244-53
24531722
CA Cancer J Clin. 2014 Jul-Aug;64(4):252-71
24890451
Stem Cells Dev. 2013 May 1;22(9):1455-76
23336433
Blood. 2011 Dec 1;118(23):6141-52
21998208
Cancer Biol Ther. 2007 Mar;6(3):426-31
17471030
J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):253-60
20354771
Cancer Sci. 2010 Dec;101(12):2561-9
20874842
Nat Med. 1997 Jul;3(7):730-7
9212098
Pathol Oncol Res. 2013 Oct;19(4):811-4
23653114
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8
12629218
Breast Cancer Res. 2008;10(2):R25
18366788
Cancer Res. 2010 Apr 15;70(8):3005-8
20395197
Cancer Lett. 2013 Nov 28;341(1):9-15
23462225
Clin Exp Metastasis. 2013 Jun;30(5):671-80
23508889
Oncoimmunology. 2013 Sep 1;2(9):e26246
24319640
Stem Cells. 2011 Jan;29(1):32-45
21280157
Am J Transl Res. 2014 Jan 15;6(2):129-39
24489992
Br J Cancer. 2014 Apr 15;110(8):2063-71
24577057
Georgian Med News. 2014 Mar;(228):81-7
24743129